Genoskin

Accelerating #antiaging trials using real human #skin... @Genoskin can help de-risk antiaging trials with the only live human skin model available for subcutaneous administration testing. #longevity #biotech bit.ly/3BmdVpL

📢 Publication alert! 📢 MANTIS® our groundbreaking analytic pipeline is published in @ScienceMagazine Advances! It revolutionizes immune phenotyping in skin samples, unraveling complex inflammatory conditions. bit.ly/3ClDF8U #ScienceAdvances #Innovation #Immunology

🔥 Very excited to announce the preprint of our #academic article on the MANTIS® #spatialbiology platform under the title: "3-D deconvolution of human skin #immune architecture with Multiplex Annotated Tissue Imaging System (MANTIS®)". bit.ly/3XO6xPA

🐰 Happy #ChineseNewYear2023 to everyone! As serendipity will have it, 2023 is the year of the rabbit and therefore provides the perfect timing to focus on #animalfree #drug and #vaccine research! Learn more here 👇 genoskin.com

🚨 If you're in the #Boston area, come meet our CSO and #immunology expert, Dr. Nicolas Gaudenzio! 🎯 He'll be in Kendall Sq. on Feb 2, 2023 to present our bio-stabilized skin model for high-dimensional #profiling of immune response to #injectable drugs. bit.ly/3IX5gBz

🙏 A huge thank you to all our amazing customers, donors, and teams in France and in the US, for an amazing 2022! 🎄Happy holidays to all! Here's to an even better 2023! #thankyou

🎟 We’re delighted to announce that @Evotec Toulouse and Michael Esquerré, VP Immuno-Oncology, have invited Nicolas Gaudenzio, our CSO and Research Director of the @InsermOccPy Infinity Lab, for a live #evoseminar presentation at the Curie Campus in Toulouse on January 10th!

🚨 Last chance to register for tomorrow's @LeicaMicro #MicroscopyFocus #webinar with Dr Nicolas Gaudenzio, our CSO, on an easy way to perform 10+/- color #imaging of tissue samples to assess the skin #immune landscape. Don't miss out ! bit.ly/leica-mantis-w…

💡Discover a unique, simple method to perform 10+/-color #imaging of #tissue samples and assess the skin #immune landscape. Join Dr. Nicolas Gaudenzio for an exciting @LeicaMicro #MicroscopyFocus webinar on Dec. 7th 2022 to learn more. Register now! bit.ly/3Fgyo4G

🎟 Last chance to meet the Genoskin team in the US this year! Come join Eric Merle, our Chief Business Innovation Officer, in #Boston next week, during the upcoming #LipidNanoparticles Immunogenicity & Toxicity Summit. lnp-immunogenicity-toxicity-summit.com

🚀 Today is #spatialbiology day at the joint annual meeting of the @sfiimmunologie! Check out the #dataanalysis session in the Athena Auditorium (level 2) from 11:45 am to 1:15 pm and learn all about our MANTIS® #multiplex imaging solution!

🚨 Come join us at the 6th Annual #Dermatology Drug Development Summit for #Inflammatory Skin #Diseases in #Boston on November 2-3 and discover our unique solutions for dermatological #research and #DrugDevelopment! dermatology-drugdevelopment.com

💡Come join Dr. Nicolas Gaudenzio, our Chief Scientific Officer, during the @crctoncopole #Workshop on Computational Analysis and #Multiomics in Oncology at the @IUCTOncopole auditorium in #Toulouse Monday, October 17. Don't miss out! crct-inserm.fr/evenement/work…

🚨 New #jobalert in our labs in #Toulouse! If you hold a #PhD in #Immunology, Genoskin is actively #recruiting a Senior Study #Director. Come join our amazing team and help us accelerate and secure #DrugDevelopment! Check out the job offer below👇 genoskin.com/blog/2022/10/1…

🇪🇸 If you're at the #WVCEU @vaccinenation Congress in Barcelona, come meet the Genoskin team at booth # 1! 💉See how we evaluate #vaccine #efficacy and injection site #reactions after #subcutaneous and #intradermal injections or #transdermal patch administration. See you there!

🤔 Today’s #research on new #drugs is often complicated by a lack of relevant study tools. 💡 Genoskin now provides a reliable solution to help you #evaluate human primary #MastCell #response to your compound or formula. Read more here 👇 genoskin.com/human-mast-cel…

Un grand merci à @BFMTV de nous avoir invités pour l’émission Tech & Co hier! Genoskin est parmi les 4 finalistes (catégorie Santé) pour le #TechforGoodAwards cette année! Découvrez l’#interview avec Eric Merle: bit.ly/BFMitvw @FRdigitale @bfmbusiness @TechForGoodBFM

We’re delighted to announce that @Genoskin is among the 4 finalists of @BFMTV’s and @FRdigitale @TechForGoodBFM Awards this year! Tune in to Tech & Co on Oct 6th-8:30pm CET and learn from Eric Merle, our CBIO, how we help change the way drugs are currently developed !

🚨 Last chance to register for our Sept 30th webinar on the #neuroimmune regulation of #itch! 💡The webinar features @itchdoctor Dr Brian S. Kim and tackles the #biology and #clinical perspectives of itch in skin #inflammation. Register now! bit.ly/twt2itch